Evidence map›Paper›PMID 18241617›Full record

ReviewCurrent atherosclerosis reports2007

Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome.

Ebru Erbay, Haiming Cao, Gökhan S Hotamisligil

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current atherosclerosis reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ebru ErbayDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Haiming Cao
Gökhan S Hotamisligil
Harvard University · US

Funding

ROLE OF FATTY ACID BINDING PROTEINS IN ATHEROSCLEROSISR01HL065405 · NHLBI · VANDERBILT UNIVERSITY · PI LINTON, MACRAE F · 2000 to 2009
$4.0M
Lipids, Inflammation and Insulin ActionR01DK064360 · NIDDK · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HOTAMISLIGIL, GOKHAN S · 2004 to 2013
$3.7M
Lipids, Inflammation and Insulin ActionR56DK064360 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI HOTAMISLIGIL, GOKHAN S · 2008 to 2008
$163k
NHLBI NIH HHS HL065405NIDDK NIH HHS DK64360
6 · The paper itself

Abstract

The link between inflammation and the development of insulin resistance, type 2 diabetes, and atherosclerosis has been uncovered in the past decade. Although the molecular mechanisms underlying the co-occurrence of these metabolic and inflammatory diseases are not fully understood, several molecular players, integrating stress and inflammatory responses with metabolic homeostasis, were discovered recently. One of these molecular integration sites is through the action of cytosolic lipid chaperones or fatty acid binding proteins (FABPs), which are common to adipocytes and macrophages. Furthermore, studies in a variety of genetic models demonstrated that the FABPs aP2 and mal1 are critical mediators of many components of metabolic syndrome in mice. These exciting findings raise the possibility that FABPs represent desirable therapeutic targets for metabolic syndrome. In this review, we describe the findings demonstrating FABP's role in metabolic and inflammatory diseases and highlight recent advances in understanding the mechanisms of FABP function at the cellular and molecular level.

Indexed as

AdipocytesAnimalsAsthmaAtherosclerosisDiabetes MellitusFatty Acid-Binding ProteinsHepatocytesHumansInflammationInsulin ResistanceMacrophagesMetabolic SyndromeObesityFatty Acid-Binding Proteins

Identifiers

PMID18241617
OpenAlexW2077126724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.